Cataract‑Induced Glaucoma

Overview

Cataract‑induced glaucoma (sometimes called secondary open‑angle glaucoma caused by lens changes) occurs when a cataract – a clouding of the eye’s natural lens – alters the anatomy of the anterior chamber and obstructs the normal outflow of aqueous humor. The resulting pressure buildup can damage the optic nerve, leading to glaucoma‑type vision loss.

Who it affects

• Adults over the age of 60 are most commonly affected, because cataracts and primary open‑angle glaucoma both increase with age.
• People with a history of ocular trauma, uveitis, or previous eye surgery are at higher risk.
• Certain ethnic groups (e.g., African‑American, Hispanic, and Asian populations) have a higher baseline risk for glaucoma, which can be amplified by cataract formation.

Prevalence

According to the World Health Organization, cataracts affect roughly 200 million people worldwide. Studies estimate that 2–5 % of patients with dense cataracts develop secondary glaucoma before the lens is removed, and the risk rises to 10–15 % in eyes with pre‑existing narrow angles or pseudoexfoliation syndrome ¹.

Symptoms

Symptoms may be subtle early on because cataract vision loss often masks the rise in intra‑ocular pressure (IOP). When glaucoma progresses, the following signs may appear:

• Gradual loss of peripheral vision – “tunnel vision” that starts at the outer edges.
• Blurred or hazy vision – worsening of the cloudiness already caused by the cataract.
• Halos around lights – especially at night.
• Eye pain or discomfort – may be mild, but can become acute if pressure spikes.
• Redness of the eye – a sign of inflammation or elevated pressure.
• Headache – often described as a dull ache behind the eyes.
• Reduced ability to adapt to darkness – taking longer to see when lights are turned off.
• Nausea or vomiting – typically only with an acute pressure emergency.

Because cataract patients already notice “blurry” vision, any sudden change in the visual field or new eye pain should prompt an ophthalmic evaluation.

Causes and Risk Factors

Pathophysiology

In a healthy eye, aqueous humor is produced by the ciliary body, circulates through the pupil, and drains primarily via the trabecular meshwork into Schlemm’s canal. A mature cataract can cause:

1. Lens swelling (phacomorphic changes) – The lens enlarges and pushes the iris forward, narrowing the anterior chamber angle.
2. Lens subluxation – Dislocation of the cataractous lens can physically block the drainage pathways.
3. Inflammatory response – Cataract progression may trigger uveitis, which can clog the trabecular meshwork.

Risk Factors

• Age ≥ 60 years.
• Family history of glaucoma.
• Pre‑existing narrow‑angle anatomy (e.g., shallow anterior chamber).
• High myopia (nearsightedness).
• Systemic steroid use or ocular steroid injections.
• Diabetes mellitus – associated with faster cataract formation and vascular changes that affect outflow.
• History of eye trauma or prior intra‑ocular surgery.
• Ethnicity: African‑American, Hispanic, and Asian descent.

Diagnosis

Clinical Examination

• Visual acuity test – Determines the level of vision loss from cataract and glaucoma.
• Slit‑lamp biomicroscopy – Allows the clinician to see lens opacity, iris configuration, and any inflammatory cells.
• Gonioscopy – Directly visualizes the angle of the anterior chamber to assess narrowing or closure.

Diagnostic Tests

• Intra‑ocular pressure measurement (tonometry) – Goldmann applanation tonometry is the standard; pressures > 21 mmHg are suspicious.
• Optic nerve imaging (OCT) – Optical Coherence Tomography evaluates retinal nerve fibre layer (RNFL) thickness.
• Visual field testing (perimetry) – Detects characteristic peripheral loss.
• Anterior segment OCT or Ultrasound Biomicroscopy (UBM) – Provides cross‑sectional images of the angle and lens thickness.

When cataract opacity hinders view of the optic nerve, surgeons may rely more heavily on OCT and visual field trends.

Treatment Options

Medical Management

• Topical ocular hypotensive agents – prostaglandin analogs (latanoprost), beta‑blockers (timolol), α‑agonists (brimonidine), or carbonic anhydrase inhibitors (brinzolamide).
• Systemic carbonic anhydrase inhibitors (acetazolamide) – Used for short‑term pressure spikes.
• Anti‑inflammatory drops – Steroid or non‑steroidal eye drops if inflammation contributes to outflow obstruction.

Medical therapy aims to lower IOP to ≤ 18 mmHg or at least 20 % below baseline, but it rarely addresses the underlying angle closure caused by the cataract.

Surgical Options

1. Cataract extraction (phacoemulsification) with intra‑ocular lens (IOL) implantation – By removing the swollen lens, the anterior chamber deepens and the angle widens. In many cases, this alone normalizes IOP.
2. Combined cataract‑glaucoma surgery – For eyes with persistent high pressure after lens removal, surgeons may add a minimally invasive glaucoma surgery (MIGS) device (e.g., iStent, Hydrus) or perform a trabeculectomy.
3. Laser peripheral iridotomy (LPI) – Used when a pupillary block component exists; creates a tiny hole in the iris to equalize pressure.
4. Laser trabeculoplasty (SLT or ALT) – Improves trabecular outflow; often adjunctive after cataract surgery.

Lifestyle & Home Measures

• Limit caffeine and high‑sodium foods that can raise IOP.
• Engage in regular aerobic exercise (e.g., brisk walking) – shown to modestly lower IOP.
• Avoid head‑down positions for prolonged periods (e.g., yoga inversions).
• Use protective eyewear to prevent trauma.

Living with Cataract‑Induced Glaucoma

Daily Management Tips

• Medication adherence – Set alarms or use a dosing tracker; missing drops can quickly raise pressure.
• Regular eye‑doctor visits – Typically every 3–6 months after stabilization, more often if pressure fluctuates.
• Visual aids – Magnifiers, high‑contrast reading glasses, and adequate lighting help compensate for peripheral loss.
• Home safety – Remove trip hazards, use night lights, and consider a walking cane if vision narrows.
• Monitor side effects – Stinging, redness, or blurry vision after drops may indicate intolerance; discuss alternatives with your ophthalmologist.
• Nutrition – Diets rich in leafy greens, omega‑3 fatty acids, and antioxidants support ocular health.

Emotional Well‑Being

Vision change can affect mood and independence. Joining support groups (e.g., Glaucoma Foundation’s community) and counseling can improve quality of life.

Prevention

• Control systemic risk factors: keep blood pressure, blood sugar, and cholesterol within target ranges.
• Annual comprehensive eye exams after age 40, or earlier if you have a family history of glaucoma.
• Prompt treatment of early cataracts – surgical removal before the lens becomes phacomorphic reduces the chance of secondary angle closure.
• Avoid long‑term high‑dose steroids unless absolutely necessary.
• Use UV‑protective sunglasses to slow cataract formation.

Complications

If left untreated, cataract‑induced glaucoma can lead to:

• Irreversible optic nerve damage and progressive visual field loss.
• Acute angle‑closure crisis – sudden IOP spikes causing severe pain, nausea, and possible permanent vision loss.
• Secondary corneal edema from prolonged high pressure.
• Loss of ability to drive or perform daily tasks, increasing fall risk.
• Complications of surgery such as endophthalmitis, posterior capsular rupture, or postoperative IOP spikes.

When to Seek Emergency Care

References

1. American Academy of Ophthalmology. “Secondary Glaucoma.” aao.org. Accessed 2024.
2. Mayo Clinic. “Cataract.” mayoclinic.org. 2023.
3. World Health Organization. “Blindness and vision impairment.” who.int. 2022.
4. National Eye Institute (NEI). “Glaucoma.” nei.nih.gov. 2024.
5. Cleveland Clinic. “Phacomorphic Glaucoma.” clevelandclinic.org. 2023.
6. European Glaucoma Society Guidelines, 2023. European Journal of Ophthalmology.